← FDA Drug Approvals (Drugs@FDA)

SCOPOLAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS UT INC · Approved 2022-01-10

Drug application

FDA Application #

ANDA208769

Application type

Abbreviated New Drug Application (Generic)

Brand name

SCOPOLAMINE

Generic name

SCOPOLAMINE

Active ingredients

SCOPOLAMINE

Dosage form

SYSTEM

Route

TRANSDERMAL

Marketing status

Prescription

Sponsor

ACTAVIS LABS UT INC

Manufacturer

Actavis Pharma, Inc.

First approval

2022-01-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown